The global market for cell therapy processing is estimated to grow from $2.7 billion in 2025 to reach $7.1 billion by 2030, at a compound annual growth rate (CAGR) 21.4% from 2025 to 2030.
According to the American Society of Gene and Cell Therapy (ASGCT), cell therapy is a therapeutic approach in which patients are given either normal or altered cells to treat illnesses. In this treatment, patients receive injections of intact, living human cells that are thought to have therapeutic potential.
The foundation of cell treatments is the idea that cells can be genetically reprogrammed to fight various illnesses, either by using the patient’s own cells (autologous) or cells from a healthy donor (allogeneic). These treatments, such as small-molecule medications, have become strong substitutes for conventional therapy. It is important to note that there have been numerous advances in this field over the last few decades, especially in the production process for cell therapy.
The report focuses on the significant driving trends and challenges that affect the market. It analyzes environmental, social and corporate governance (ESG) developments. It includes an analysis of the competitive landscape and has a dedicated section of company profiles that covers such details as overview, key financials, product portfolio and recent developments of key market players.
According to the American Society of Gene and Cell Therapy (ASGCT), cell therapy is a therapeutic approach in which patients are given either normal or altered cells to treat illnesses. In this treatment, patients receive injections of intact, living human cells that are thought to have therapeutic potential.
The foundation of cell treatments is the idea that cells can be genetically reprogrammed to fight various illnesses, either by using the patient’s own cells (autologous) or cells from a healthy donor (allogeneic). These treatments, such as small-molecule medications, have become strong substitutes for conventional therapy. It is important to note that there have been numerous advances in this field over the last few decades, especially in the production process for cell therapy.
Report Scope
The report provides an overview of global cell therapy processing and analyzes market trends. It includes global revenue ($ millions) for the base year data 2024 and estimated data for 2025 with forecasts through 2030. The market is segmented based on offering type, application and regions. By offering, the market is segmented into products, software and services. By application, the market is segmented into cancer, musculoskeletal disorders, neurological disorders, cardiovascular diseases and others. The regions covered in this study are North America, Europe, Asia-Pacific, the Middle East, Africa, and South America, focusing on the major countries in these regions. The North American region includes the U.S., Canada and Mexico. Europe includes Germany, the U.K., Italy, France, Spain and the Rest of Europe; Asia-Pacific includes China, Japan, India, South Korea, and the Rest of Asia-Pacific.The report focuses on the significant driving trends and challenges that affect the market. It analyzes environmental, social and corporate governance (ESG) developments. It includes an analysis of the competitive landscape and has a dedicated section of company profiles that covers such details as overview, key financials, product portfolio and recent developments of key market players.
The report includes:
- 32 data tables and 58 additional tables
- An overview of the global market and technologies for cell therapy processing
- In-depth analysis of global market trends, featuring historical revenue data for 2022-2024, estimated figures for 2025, as well as forecasts for 2030. This analysis includes projections of compound annual growth rates (CAGRs) through 2030
- Evaluation of the current market size and revenue growth prospects specific to the cell therapy processing, accompanied by a market share analysis by offerings, application and region
- Analysis of current and future demand in the global cell therapy processing market, along with a detailed analysis of the competitive environment, market regulations and reimbursement practices
- Analysis of drivers, challenges and opportunities affecting market growth
- Coverage of evolving technologies, the current and future market potential, R&D activities, growth strategies, new product pipeline, regulatory framework and reimbursement scenarios and ESG trends of the market
- Market share analysis of the key market participants in the cell therapy processing market, along with their research priorities, product portfolios, global rankings and company competitive landscape
- Profiles of the major companies, including Thermo Fisher Scientific Inc., Danaher Corp., Lonza, Miltenyi Biotech and Sartorius AG
Table of Contents
Chapter 1 Executive Summary
Chapter 2 Market Overview
Chapter 3 Market Dynamics
Chapter 4 Regulatory Landscape
Chapter 5 Emerging Technologies and Developments
Chapter 6 Market Segment Analysis
Chapter 7 Competitive Intelligence
Chapter 8 Sustainability in Cell Therapy Processing Market: An ESG Perspective
Chapter 9 Appendix
List of Tables
List of Figures
Companies Mentioned
- Bio-Techne
- Biospherix LLC.
- Cytiva
- Fresenius Kabi AG
- Fujifilm Biosciences
- Lonza
- Merck KGaA
- Miltenyi Biotec
- Proteintech Group Inc.
- Revvity
- Sartorius AG
- Stemcell Technologies
- Terumo Corp.
- Thermo Fisher Scientific Inc.
- Thermogenesis
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 125 |
| Published | October 2025 |
| Forecast Period | 2025 - 2030 |
| Estimated Market Value ( USD | $ 2.7 Billion |
| Forecasted Market Value ( USD | $ 7.1 Billion |
| Compound Annual Growth Rate | 21.4% |
| Regions Covered | Global |
| No. of Companies Mentioned | 15 |
